Meropenem: a microbiological overview

Journal of Antimicrobial Chemotherapy

Volumn 36, Issue , 1995, Pages 1-17

  Edwards, J R ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; MEROPENEM; PENICILLIN BINDING PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE MODEL; DRUG BINDING; DRUG STABILITY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GUINEA PIG; HAEMOPHILUS INFLUENZAE; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION;

ANIMAL; BACTERIAL INFECTIONS; CARBAPENEMS; HUMAN; THIENAMYCINS;

EID: 0029027063     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/36.suppl_A.1     Document Type: Article

References (74)

1. Aguiar, J-M., Chacon, J., Canton, R. & Baquero, F. (1992). The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. Journal of Antimicrobial Chemotherapy 29, 349-50
2. Appleman, M. D., Cherubin, C. E, Heseltine, P. N. R. & Stratton, C. W. (1991). Susceptibility testing of Listeria monocytogenes: a reassessment of bactericidal activity as a predictor for clinical outcome. Diagnostic Microbiology anti Infectious Diseases 14, 311-7
3. Bauemfeind, A., Grimm, H. & Schweighart, S (1990). A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18, 294-8
4. Bauernfeind, A., Jungwirth, R., & Schweighart, S. (1989). In-vitro activity of meropenem, imipenem, and penem HRE664 and ceftazidime against clinical isolates from West Germany. Journal of Antimicrobial Chemotherapy 24, Suppl. A. 73-84
5. Bax, R. P., Bastian, W., Featherstone, A., Wilkinson, D M., Hutchison, M. & Haworth, S. J. (1989). The pharmacokinetic of meropenem in volunteers. Journal of Antimicrobial Chemotherapy 24, Suppl A, 31 1-320
6. Bergogne-Berezin, E., Muller-Serieys, C., Aubier, A. & Dombret, M. C. (1994). Concentrations of meropenem in serum and bronchial secretions in patients undergoing bronchoscopy. European Journal of Clinical Pharmacology 46, 87 8
7. Birnbaum, J., Kahan, F. M., Kropp, H & MacDonald, S. (1985). Carbapenems, a new class of β-lactam antibiotics. Discovery and development of imipenem/cilastatin. American Journal of Medicine 78, Suppl. 6A, 3-21
8. Chanal, C., Sirot, D., Chanal, M, Cluzel, M., Sirot, J. & Cluzel, R. (1989). Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum β-lactamases Journal of Antimicrobial Chemotherapy 24, Suppl. A, 133-41
9. Clarke, A M., & Zemcov, S. J. V., (1989) In-vitro activity of meropenem against clinical isolates obtained in Canada. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 47-55
10. Craig, A. W. & Ebert, S. C., (1992). Continuous infusion of β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 36, 2577-83
11. Dagan, G., & Klugmann, K. P., (1994). Penetration of meropenem into the CSF of paediatric patients with meningitis. In Programme and Abstracts of the Sixth European Congress of Clinical Microbiology and Infectious Disease, Seville. 1994. Abstract 261
12. Debbia, E A., Milinari, G., Pesce, A. & Schito, G.-C. (1992). Antibacterial activity of meropenem, alone and in combination with other drugs, and post-antibiotic efTect. In Programme of the Eighth Mediterranean Congress of Chemotherapy. Athens. 1992. p 49
13. Drusano, G. L. (1991). Human pharmacodynamics of β -lactams, aminoglycosides and their combination. Scandanian Journal of Infectious Disease. Suppl. 74, 235-48
14. Drusano, G. L., Ryan, P. A. Standiford, H. C., Moody, M R., & Schimpff, T. S. C., (1984) Integration of selected pharmacokinetic and microbiological properties of three β -lactam antibiotics: a hypothesis for rational comparison. Reviews of Infectious Diseases 6, 357-63
15. Edwards, J. R., Turner, P. J., Wannop, C., Withnell, E. S., Grindey, A. J., & Nairn, K., (1989a). In-vitro antimicrobial activity of SM-7338. a carbapenem antibiotic with stability to dehydropeptidase I. Antimicrobial Agents and Chemotherapy 33, 215-22
16. Edwards, J. R., Williams, S., & Naim, K., (1989b). Therapeutic activity of meropenem in experimental infections. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 279-85
17. Ferrara, A., Grassi, G., Grassi, F. A., Piccioni, P. D., & Gialdroni Grassi, G., (1989)
18. Bactericidal activity of meropenem and interactions with other antibiotics. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 239-50
19. Friedland, I. R., Jafari, H., Ehrett, S., Rinderknecht, S., Paris, M., Coulthard, M., et at. (1993a). Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. Journal of Infectious Diseases 168, 657-62
20. Friedland, I. R., Paris, M., Ehrett, S., Hickey, S., Olssen, K. & McCracken, G. H., (19936). Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumoccal meningitis. Antimicrobial Agents and Chemotherapy 37, 1630-6
21. Fukasawa, M., Sumita, Y., Harabe, E. T., Tanio, T., Nouda, H., Kohzuki, T., etal. (1992). Stability of meropenem and effect of l-β-methyl substitution on its stability in the presence of renal dehydropeptidase I. Antimicrobial Agents and Chemotherapy 36, 1577-9
22. Garcia de Lomas, J., Perez-Saborit, F. J. & Gimeno, C. (1992). Outer membrane proteins and susceptibility to carbapenems. Spanish Journal of Chemotherapy 5, Suppl. 4, 11-5
23. Garcia-Rodriguez, J. A., Garcia Sanchez, J. E., Trujillano, I. & Sanchez de San Lorenzo, A. (1991). Meropenem: in-vitro activity and kinetics of activity against organism of the Bacteroidesfragilis group. Journal of Antimicrobial Chemotherapy 27, 599-606
24. Gobemado, M. & Canton, E. (1992). Influence of pH and inoculum size on the in-vitro activity of meropenem. Spanish Journal of Chemotherapy 5, Suppl. 4, 7-10
25. Hutchison, M., Faulkner, K. L., Turner, P. J., Haworth, S. J., Sheikh, W., Nadler, H. et al. (1995). A compilation of meropenem tissue distribution data. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 43-56
26. Inderlied, C. B., Lancero, M. G. & Young, L. S. (1989). Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 85-99
27. Jones, R. N., Aldridge, K. E., Allen, S. D., Barry, A. L., Fuchs, P. C., Gerlach, E. H. et al. (1989a). Multicenter in-vitro evaluation of SM-7338, a new carbapenem. Antimicrobial Agents and Chemotherapy 33, 562-5
28. Jones, R. N., Barry, A. L., & Thomsberry, C., (1989b). In-vitro studies of meropenem. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 9-29
29. Jorgensen, J. H., Maher, L. A. & Howell, A. W. (1991). Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with β-lactamase and non-enzyme-mediated resistance to ampicillin. Antimicrobial Agents and Chemotherapy 35, 600-2
30. Kayser, F. H., Morenzoni, G., Strassle, A. & Hadorn, K. (1989). Activity of meropenem against Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 101-12
31. Kitzis, M. D., Acar, J. F. & Gutmann, L. (1989). Antibacterial activity of meropenem against Gram-negative bacteria with a permeability defect and against staphylococci. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 125-32
32. Kitzis, M. D., Liassine, N., Ferre, B., Gutmann, L., Acar, J. F. & Goldstein, F. (1990). In-vitro activity of 15 oral β-lactams against Klebsiella pneumoniae harbouring new extended spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 34, 1783-6
33. Labia, R., Morand, A., Tiwari, K., Sirot, D. & Chanal, C. (1989). Interactions of meropenem with β-lactamases, including new enzymes with extended-spectrum activity against third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 219-23
34. Lee, E. H, Nicolas, M. H, Kitzis, M. D, Pialoux, G, Collatz, E. & Gutmann, L. (1991). Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high level resistance to imipenem. Antimicrobial Agents and Chemotherapy 35, 1093-8
35. Livermore, D. M. (1992a). Interplay of impermeability and chrosomal /Mactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 2046-8
36. Livermore, D. M. (1992b). Carbapenemases. Journal of Antimicrobial Chemotherapy 29, 609-13
37. Margaret, B. S., Drusano, G. L. & Standiford, H. C. (1989). Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 161-7
38. Martin-Luengo, F., Baquero, F., Bouza, E., Cistema, R., Garcia de Lomas, J., Garcia Rodriguez, J.-A. et al (1992). Comparative in-vitro activity of meropenem and other antimicrobials against clinical isolates. Spanish Journal uj Chemotherapy 5, Suppl. 4, 45-8
39. Martinez-Martinez, L., Suarez, A. I., Carranza, R. & Perea, E. J. (1993). Ciprofloxacin resistance in Gram-negative bacilli Epidemiologic aspects. Enjermedades Infecciosas y Microbiologia Climica 11, 474 8
40. Matsuda, S. (1993). Pharmocokinetics and clinical studies of meropenem in the field of obstetric and gynecological infection. Journul of Chemotherapy 5, Suppl. A, 143-146
41. Moellering, R C, Eliopoulos, G. M. & Sentochnik, D. E. (1989). The carbapenems: new broad spectrum β-lactam antibiotics Journal of Antimicrobial Chemotherapy 24, Suppl. A, 1-7
42. Murray, P. R. & Niles, A. C. (1990). In-vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates. Diagnostic Microbiology and Infectious Diseases 13, 57-61
43. Nadler, H., & Sheikh, W. (1989). The postantibiotic effect of meropenem and imipenem on selected bacteria. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 225-31
44. Nadler, H., Pitkin, D. H. & Sheikh, W., (1993). A comparison of the in-vitro postantibiotic effect of meropenem and imipenem versus selected Enterobacteriacae and other pathogens. Diagnostic Microbiology and Infectious Diseases 17, 57-61
45. Naganuma, H., Tokiwa, H., Hirouchi, Y., Kawahara, Y., Fukushiga, J.-l. & Fujami, M. (1991). Nephroprotective effect and its mechanism of betamipron (1)-relationship of renal transport. Chemotherapy (Tokyo) 39, Suppl. 3, 166-77
46. Nairn, K., Shepherd, G. L. & Edwards, J. R. (1995). Efficacy of meropenem in experimental meningitis. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 73-84
47. Neu, H. C., Novelli, A. & Chin, N.-X (1989). In-vitro activity and β-lactamase stability of a new carbapenem SM-7338. Antimicrobial Agents and Chemotherapy 33, 1009-18
48. Nilsson-Ehle, I., Hutchison, M., Haworth, S. J. & Norrby, S. R. (1991). Pharmacokinetics of meropenem compared to imipenem/cilastatin in young, healthy males. European Journal of Clinical Microbiology and Infectious Disease 10, 85-8
49. Nord, C. E., Lindmark, A. & Persson, I. (1989). Susceptibility of anaerobic bactena to meropenem. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 113-7
50. Nordmann, P., Mariotte, S., Naas, T., Labia, R. & Nicolas, M.-H. (1993). Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrobial Agents and Chemotherapy 37, 939-46
51. Papanicolaou, G. A., Medeiros, A. A. & Jacoby, A K. (1990). New plasmid mediated β-lactamases (MIR-I) conferring resistance to oxyamino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 34, 2200-9
52. Phillips, I., King, A., Gransden, W. R. & Eykyn, S. J (1990). The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas’ Hospital, 1969-1988. Journal of Antimicrobial Chemotherapy 25, Suppl. C, 59-80
53. Quentin, C., Loup Avril, J, Bebear, C., Dabemat, L., Dubreuil, L., Meyran, M. et at. (1992). Comparative in-vitro activity of meropenem on clinical isolates from France. Spanish Journal of Chemotherapy 5, Suppl. 4, 53-9
54. Quinn, J. P., Dudeck, E. J., Di Vincenzo, C. A., Lucks, D. A. & Lemer, S. A. (1986). Emergence of resistance to imipenem therapy during therapy for Pseudomonas aeruginosa infections. Journal of Infectious Diseases 154, 289-94
55. Ravizzola, G., Pinsi, G., Gonzales, R., Colombrita, D., Pirali, F., & Turano, A., (1989). Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates. European Journal of Clinical Microbiology and Infectious Diseases 8, 1053-61
56. Sanders, C. C. & Sanders, W. E. (1992). β-Lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clinical Infectious Diseases 15, 824-39
57. Sanders, C. C., Sanders, W. E., Thompson, K. S. & Iaconis, J. P. (1989). Meropenem: activity against resistant Gram-negative bacteria and interactions w'ith β-lactamases. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 187-96
58. Satake, S., Yoshihara, E. & Nakae, T. (1990). Diffusion of β-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membranes of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 34, 685-90
59. Schito, G. C., Sanna, A., Chezzi, C., Ravizzola, G., Leone, F., Molinari, G. et al. (1989). In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy. Journal of Antimicrobial Chemotherapy 24, Suppl. A, 57-72
60. Shah, P. & Stille, W. (1992). Activity of meropenem and other antimicrobials against Enterobacteriaceae and Pseudomonas aeruginosa isolated in Frankfurt during 1989 and 1991. Spanish Journal of Chemotherapy 5, Suppl 4. 61-4
61. Sumita, Y. Fukasawa, M. & Okuda, T.(1990a). Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus.Antimicrobial Agents and Chemotherapy 34, 484-6
62. Sumita, Y., Fukasawa, M. & Okuda, T (1990b). Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and its release from these proteins and morphological changes. Journal of Antibiotics 43, 314-20
63. Sunagawa, M., Matsumura, H., Inoue, T., Fukasawa, M. & Kato, M. (1990). A novel carbapenem antibiotic, SM-7338 structure-activity relationships. Journal of Antibiotics 43, 519-32
64. Turner, P. J. & Edwards, J. R., (1994). Meropenem: an evaluation conducted in 82 European laboratories. In Programme and Abstracts of the Sixth International Congress for Infectious Disease, Prague, 1994 Abstract 1287, p. 396
65. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy 25, 891-902
66. Wiedemann, B. & Zuhlsdorf, M. (1989) Antibacterial properties of meropenem towards clinical isolates, β-lactamase producers and laboratory mutants. Journal of Antimicrobial Chemotherapy 24, Suppl A. 197-205
67. Wise, R. & Andrews, J. M (1992). Penetration of meropenem into peritoneal fluid. In Meropenem. a new carbapenem. In Programme of the Eighth Mediterranean Congress of Chemotherapy, Athens, 1992. pp. 30-32
68. Wise, R., Ashby, J. P & Andrews, J. M. (1989). The antibacterial activity of meropenem in combination with gentamicin or vancomycin Journal of Antimicrobial Chemotherapy 24, Suppl. A, 233-8
69. Wise, R, Logan, M., Cooper, M., Ashby, J. P & Andrews, J. M. (1990). Meropenem pharmacokinetics and penetration into an inflammatory exudate Antimicrobial Agents and Chemotherapy 34, 1515-7
70. Yamamoto, T., Naigowit, P., Dejsinlet, S, Chiewsilp, D., Kondo, E., Yokota, T. et al (1990). In-vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents Antimicrobial Agents and Chemotherapy 34, 2027-9
71. Yang, Y. & Livermore, D. M. (1989). Interactions of meropenem with class I chromosomal β-lactamases. Journal of Antimicrobial Chemotherapy 24, Suppl A, 207-17
72. Yang, Y., Puijun, W. & Livermore, D. M. (1990) Biochemical characterisation of a β-lactamase that hydrolyses penems and carbapenems from two Serrutia marcescens isolates. Antimicrobial Agents and Chemotherapy 34, 755-8
73. Yango, B. G., Halkias, K. D. & Chmel, H. (1990). Activity of newer antimicrobials against rapidly growing mycobacteria. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA 1990. Abstract 869 American Society for Microbiology, Washington, DC
74. Yourassowsky, E., Van der Linden, M. F., Lismont, M J., Crokaert, F & Glupczynski, Y. (1989). Bactericidal activity of meropenem against Pseudomonas aeruginosa.Journal of Antimicrobial Chemotherapy 24, Suppl. A, 169-74